Literature DB >> 16963136

An ITIM-like motif within the CCK2 receptor sequence required for interaction with SHP-2 and the activation of the AKT pathway.

Sébastien Vatinel1, Audrey Ferrand, Fréderic Lopez, Aline Kowalski-Chauvel, Jean-Pierre Estève, Daniel Fourmy, Marlène Dufresne, Catherine Seva.   

Abstract

SHP-2 is a tyrosine phosphatase which functions as a positive regulator downstream of RTKs, activating growth-stimulatory signalling pathways. To date, very few G protein-coupled receptors (GPCRs) have been shown to be connected to SHP-2 and very little is known about the positive role of SHP-2 in GPCR signalling. The CCK2 receptor (CCK2R), a GPCR, is now recognized to mediate mitogenic effects of gastrin on gastrointestinal cells. In the present study, we demonstrate the role of SHP-2 in the activation of the AKT pathway by the CCK2R in COS-7 cells transfected with the CCK2R and in a pancreatic cancer cell line expressing the endogenous receptor. Using surface plasmon resonance analysis, we identified a highly conserved ITIM motif, containing the tyrosine residue 438, located in the C-terminal intracellular tail of the CCK2R which directly interacts with the SHP-2 SH2 domains. The interaction was confirmed by pull down assays and co-immunoprecipitation of the receptor with SHP-2. This interaction was transiently increased following gastrin stimulation of the CCK2R and correlated with the tyrosine phosphorylation of SHP-2. Mutational analysis of the key ITIM residue 438 confirmed that the CCK2R ITIM sequence is required for interaction with SHP-2 and the activation of the AKT pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16963136     DOI: 10.1016/j.bbamcr.2006.07.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor contains an immunoreceptor tyrosine-based inhibitory motif that activates Shp2.

Authors:  Nicola Philpott; Thomas Bakken; Christopher Pennell; Liwei Chen; Jie Wu; Mark Cannon
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

2.  Regulation of membrane cholecystokinin-2 receptor by agonists enables classification of partial agonists as biased agonists.

Authors:  Rémi Magnan; Bernard Masri; Chantal Escrieut; Magali Foucaud; Pierre Cordelier; Daniel Fourmy
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

3.  Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes.

Authors:  Melinda D Willard; Mary E Lajiness; Isabella H Wulur; Bo Feng; Michelle L Swearingen; Mark T Uhlik; Kenneth W Kinzler; Victor E Velculescu; Tobias Sjöblom; Sanford D Markowitz; Steven M Powell; Bert Vogelstein; Thomas D Barber
Journal:  Mol Cancer Res       Date:  2012-04-19       Impact factor: 5.852

4.  CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells.

Authors:  Terry W Moody; Bernardo Nuche-Berenguer; Paola Moreno; Robert T Jensen
Journal:  J Mol Neurosci       Date:  2015-03-12       Impact factor: 3.444

5.  A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils.

Authors:  Ariel Munitz; Melissa L McBride; Joshua S Bernstein; Marc E Rothenberg
Journal:  Blood       Date:  2008-03-03       Impact factor: 22.113

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.